Nutex Health, Inc. / Fundamentals
Income statement
- Net revenue
€538.50M - Cost of goods sold
€275.89M - Gross profit
€262.61M - SG&A expenses
€51.65M - R&D expenses
€0.00 - EBITDA
€184.72M - D&A
€17.15M - EBIT
€173.71M - Interest expenses
€18.64M - EBT
€148.94M - Tax expenses
€28.14M - Net income
€83.47M
Cash flow statement
- Net deferred tax
-€11.33B - Non-cash items
-€3.00B - Changes in working capital
-€95.70M - Operating cash flow
€61.30M - Capex
€1.35M - Other investing cash flow
-€2.35M - Net investing cash flow
-€1.72M - Total cash dividends paid
-€5.90M - Issuance of common stock
€7.93B - Debt repayment
-€3.77M - Other financing cash flow
€7.80M - Net financing cash flow
-€9.84M - Foreign exchange effects
€0.00 - Net change in cash
€49.74M - Cash at end of period
€75.62M - Free cash flow
€62.66M
Balance sheet
- Cash and cash equivalents
€75.62M - Cash and short-term investments
€75.62M - Total receivables
€254.53M - Inventory
€2.69M - Other current assets
€13.50M - Total current assets
€346.34M - Property, plant & equipment
€276.11M - Goodwill
€12.01M - Intangible assets
€13.12M - Long-term investments
€0.00 - Other non-current assets
€602.09K - Total non-current assets
€310.88M - Total assets
€657.22M - Accounts payable
€17.11M - Short-term debt
€20.50M - Other current liabilities
€22.16M - Total current liabilities
€152.30M - Long-term debt
€249.06M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€18.75M - Total non-current liabilities
€267.81M - Total liabilities
€420.11M - Common stock
€5.18K - Retained earnings
-€295.23M - Other equity
€0.00 - Total equity
€0.00 - Total liabilities and shareholders' equity
€657.22M
Company information
- Market capitalization
€582.33M - Employees
800 - Enterprise Value
€885.61M
Company ratios
- Gross margin
-
48.8% Even with peer group: 50.5% - EBITDA margin
-
34.3% Much better than peer group: -2,808.6% - EBIT margin
-
32.3% Much better than peer group: -2,980.2% - EBT margin
-
27.7% Much better than peer group: -4,079.6% - Net margin
-
15.5% Much better than peer group: -3,171.7% - ROE
-
0.0% - ROA
-
12.7% Much better than peer group: -56.8% - Asset turnover
-
81.9% Much worse than peer group: 1,165.8% - FCF margin
-
11.1% Much better than peer group: -2,320.2% - FCF yield
10.3% - Efficiency ratio
65.7% - Net sales per employee
-
€673.13K - Net income per employee
-
€104.34K